Intranasal Oxytocin Did Not Enhance Brain Responses to Social Stimuli in Healthy Men | Research

The takeaway

A single dose of intranasal oxytocin (24 IU) did not enhance neural processing of faces compared to non-social stimuli in 31 healthy men, challenging the popular 'social salience hypothesis' of oxytocin.

Bayesian Null Confirmed
Statistical analysis provided formal evidence that oxytocin truly had no effect on social processing in healthy men — not just insufficient power to detect one

What the researchers found

In a double-blind, placebo-controlled, crossover trial with 31 healthy adult men, a single 24 IU dose of intranasal oxytocin did not modulate neural responses to social (faces) versus non-social (houses) stimuli. Frequency-tagging EEG clearly detected robust stimulus-specific neural responses — face processing was strongest in lateral occipito-temporal regions and house processing in medial occipital regions — confirming the methodology worked.

However, oxytocin did not enhance social processing, nor did it increase general information salience. Bayesian analyses formally confirmed these null findings, providing evidence of absence rather than merely absence of evidence. The researchers suggested that the neurotypical participants' baseline ceiling-level performance and the personal irrelevance of the stimuli may have prevented detection of any oxytocin effect.

Why it matters

Oxytocin has generated enormous interest as a potential treatment for autism, social anxiety, and other conditions involving social cognition difficulties. However, if oxytocin doesn't reliably enhance social processing even in well-controlled studies, the therapeutic promise may be overstated. This null result adds important nuance to the oxytocin literature and suggests the peptide's effects may depend heavily on context, individual differences, or clinical status.

How the study worked

Double-blind, placebo-controlled, crossover trial. 31 healthy adult men received either 24 IU intranasal oxytocin or placebo in two sessions. Brain responses were measured using frequency-tagging EEG: streams of faces and houses were superimposed and presented at different frequencies (6 Hz and 7.5 Hz, counterbalanced), allowing researchers to precisely isolate neural responses to each stimulus type. Four 60-second trials were recorded per session. Bayesian analyses supplemented traditional statistics.

What this study cannot tell us

Only healthy adult men were tested — results may differ in women, clinical populations, or individuals with social cognition difficulties where oxytocin effects might be more apparent. The stimuli (unfamiliar faces/houses) lacked personal relevance, which could limit sensitivity to oxytocin's effects. A single dose was used; repeated administration might produce different results. The sample size of 31, while adequate for the crossover design, is modest.

How to read the evidence

This is a well-designed double-blind, placebo-controlled, crossover clinical trial — a strong study design. The frequency-tagging EEG methodology is highly sensitive and objective. The Bayesian analysis strengthens the null finding. However, the modest sample size and restriction to healthy men limit generalizability.

When this study was published

Published in 2022, this study reflects the current period of critical re-evaluation of oxytocin's behavioral effects, following initial enthusiasm and subsequent replication difficulties in the field.

The bigger picture

The oxytocin field has faced a replication crisis, with many early findings of social enhancement failing to hold up in well-powered studies. This study contributes to a more nuanced understanding: oxytocin may not universally boost social cognition in healthy individuals. The effects may be more specific to clinical populations (e.g., autism spectrum) or particular social contexts, which is critical information for the ongoing development of oxytocin-based therapies.

Questions still open

Would oxytocin show effects on social processing in individuals with autism spectrum conditions or social anxiety, where baseline social processing is not at ceiling?
Does the 'social salience hypothesis' of oxytocin need revision to account for context-dependent or population-specific effects?
Could personally relevant social stimuli (e.g., familiar faces or emotional expressions) reveal oxytocin effects that generic faces do not?

Common questions

Does this mean oxytocin doesn't affect social behavior?

Not necessarily. This study found no effect in healthy adult men viewing generic face images. Oxytocin's effects may be more apparent in people who have social cognition difficulties (such as autism), in more personally meaningful social contexts, or with repeated dosing. The takeaway is that oxytocin doesn't universally boost social processing — its effects are likely more nuanced and context-dependent than initially believed.

What is frequency-tagging EEG and why was it used?

Frequency-tagging is a technique where different visual stimuli are presented at different rates (here, 6 Hz and 7.5 Hz). The brain's electrical activity locks onto these specific frequencies, allowing researchers to precisely separate and measure the neural response to each stimulus type — even when they're shown simultaneously. This makes it an exceptionally sensitive and objective way to detect any changes in how the brain processes different types of information.

Read the original research

Frequency-Tagging EEG of Superimposed Social and Non-Social Visual Stimulation Streams Provides No Support for Social Salience Enhancement after Intranasal Oxytocin Administration.

Brain sciences, 12(9)

View on PubMed ↗Publisher’s paper ↗

Citation

Qiao, Zhiling; Van der Donck, Stephanie; Moerkerke, Matthijs; Dlhosova, Tereza; Vettori, Sofie; Dzhelyova, Milena; van Winkel, Ruud; Alaerts, Kaat; Boets, Bart. (2022). Frequency-Tagging EEG of Superimposed Social and Non-Social Visual Stimulation Streams Provides No Support for Social Salience Enhancement after Intranasal Oxytocin Administration.. Brain sciences, 12(9). https://doi.org/10.3390/brainsci12091224